{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:49:09Z","timestamp":1785754149012,"version":"3.56.0"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Although 5-nitroimidazoles, primarily metronidazole (MTZ), are the primary drugs of choice for trichomoniasis, resistance to metronidazole appears to be increasing. Considering observed differences in drug resistance across various populations, this systematic review and meta-analysis was designed to determine the global prevalence of 5-nitroimidazole resistance among T. vaginalis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a thorough search of international databases, including Web of Science, Medline, Scopus, SID, Magiran, and Iran-Medex using a variety of relevant key-words and their synonyms. Studies meeting the inclusion criteria were selected for the meta-analysis phase. To combine the findings, we employed a random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 469 studies initially assessed, 16 were selected for the meta-analysis. Based on a random effect meta-analysis (I2 = 94.87 %, P= 0.001), the pooled prevalence rate of resistance to metronidazole was estimated at 14.8% (95% CI: 7.8\u201326.2%), which was sta-tistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The results of this study highlight the emergence of resistance to 5-nitroimidazoles, which poses a significant public health challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings emphasize the need for further research and the pursuit of new treatment options for resistant strains of T. vaginalis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715265376893251016064810","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:19:07Z","timestamp":1762240747000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global Prevalence of 5-nitroimidazole Resistance in Trichomonas vaginalis: A Systematic Review and Meta-analysis"],"prefix":"10.2174","volume":"26","author":[{"given":"Fariba","family":"Faizi","sequence":"first","affiliation":[{"name":"Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences,Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences,Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eissa","family":"Soleymani","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences,Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Maghsood","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences,Hamadan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"Rowley J.","year":"2019","unstructured":"Rowley J.; Vander H.S.; Korenromp E.; Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016. Bull World Health Organ  2019,97(8),548-562P","journal-title":"Bull World Health Organ"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/cid\/ciy079","volume":"67","author":"Patel E.U.","year":"2018","unstructured":"Patel E.U.; Gaydos C.A.; Packman Z.R.; Quinn T.C.; Tobian A.A.R.; Prevalence and correlates of Trichomonas vaginalis infection among men and women in the United States. Clin Infect Dis  2018,67(2),211-217","journal-title":"Clin Infect Dis"},{"key":"ref=3","first-page":"S47","volume":"26","author":"Debenham S.","year":"2019","unstructured":"Debenham S.; McFadden P.Z.A.; Screening and treatment of sexually transmitted infections in pregnant adolescents. Acad Emerg Med  2019,26(Suppl. 1),S47","journal-title":"Acad Emerg Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ajog.2019.10.025","volume":"221","author":"Haddad L.B.","year":"2019","unstructured":"Haddad L.B.; Kim T.G.; Young M.R.; Goggins E.R.; Workowski K.A.; Jamieson D.J.; Predictors of trichomoniasis in pregnancy: A retrospective study in a high-risk population in Atlanta, Georgia. Am J Obstet Gynecol  2019,221(6),680-681","journal-title":"Am J Obstet Gynecol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ajog.2019.10.078","volume":"221","author":"Williams R.E.","year":"2019","unstructured":"Williams R.E.; Goggins E.R.; Kim T.G.; HogenEsch E, Jamieson DJ, Haddad LB. Patterns of treatment and tests of reinfection for trichomoniasis in pregnancy at a large safety-net hospital. Am J Obstet Gynecol  2019,221(6),668-669","journal-title":"Am J Obstet Gynecol"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218349","volume":"14","author":"Joseph Davey D.L.","year":"2019","unstructured":"Joseph Davey D.L.; Nyemba D.C.; Gomba Y.; Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa. PLoS One  2019,14(7)","journal-title":"PLoS One"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/OLQ.0000000000000756","volume":"45","author":"Price C.M.","year":"2018","unstructured":"Price C.M.; Peters R.P.H.; Steyn J.; Prevalence and detection of Trichomonas vaginalis in HIV-infected pregnant women. Sex Transm Dis  2018,45(5),332-336","journal-title":"Sex Transm Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4314\/njpar.v40i1.7","volume":"40","author":"Ukatu V.E.","year":"2019","unstructured":"Ukatu V.E.; Nebenu I.; Chilaka C.G.; Attah O.A.; Evaluating Trichomonas vaginalis infection in pregnant women from two health facilities, Sokoto, Nigeria. Nigerian J Parasit  2019,40(1),46","journal-title":"Nigerian J Parasit"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1071\/SH18041","volume":"16","author":"Nguyen M.","year":"2019","unstructured":"Nguyen M.; Le G.M.; Nguyen H.T.T.; Nguyen H.D.; Klausner J.D.; Acceptability and feasibility of sexually transmissible infection screening among pregnant women in Hanoi, Vietnam. Sex Health  2019,16(2),133-138","journal-title":"Sex Health"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/cid\/ciy085","volume":"67","author":"Muzny C.A.","year":"2018","unstructured":"Muzny C.A.; Why does Trichomonas vaginalis continue to be a \u201cNeglected\u201d sexually transmitted infection? Clin Infect Dis  2018,67(2),218-220","journal-title":"Clin Infect Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejogrb.2018.06.031","volume":"228","author":"Yang S.","year":"2018","unstructured":"Yang S.; Zhao W.; Wang H.; Wang Y.; Li J.; Wu X.; Trichomonas vaginalis infection-associated risk of cervical cancer: A meta-analysis. Eur J Obstet Gynecol Reprod Biol  2018,228,166-173","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002801","volume":"8","author":"Sutcliffe S.","year":"2012","unstructured":"Sutcliffe S.; Neace C.; Magnuson N.S.; Reeves R.; Alderete J.F.; Trichomonosis, a common curable STI, and prostate carcinogenesis-a proposed molecular mechanism. PLoS Pathog  2012,8(8)","journal-title":"PLoS Pathog"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/sextrans-2012-051005","volume":"89","author":"Kissinger P.","year":"2013","unstructured":"Kissinger P.; Adamski A.; Trichomoniasis and HIV interactions: A review. Sex Transm Infect  2013,89(6),426-433","journal-title":"Sex Transm Infect"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.cr.7290169","volume":"13","author":"Dunne R.L.","year":"2003","unstructured":"Dunne R.L.; Dunn L.A.; Upcroft P.; O\u2019Donoghue P.J.; Upcroft J.A.; Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Res  2003,13(4),239-249","journal-title":"Cell Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1136\/bmj.2.5203.902","volume":"2","author":"Watt L.","year":"1960","unstructured":"Watt L.; Jennison R.F.; Clinical evaluation of metronidazole. A new systemic trichomonacide. BMJ  1960,2(5203),902-905","journal-title":"BMJ"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1071\/SH09011","volume":"6","author":"Upcroft J.A.","year":"2009","unstructured":"Upcroft J.A.; Dunn L.A.; Wal T.; Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea. Sex Health  2009,6(4),334-338","journal-title":"Sex Health"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1128\/AAC.47.4.1407-1409.2003","volume":"47","author":"Crowell A.L.","year":"2003","unstructured":"Crowell A.L.; Sanders-Lewis K.A.; Secor W.E.; In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother  2003,47(4),1407-1409","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1128\/AAC.15.2.254","volume":"15","author":"Meingassner J.G.","year":"1979","unstructured":"Meingassner J.G.; Thurner J.; Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother  1979,15(2),254-257","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00007435-198801000-00004","volume":"15","author":"M\u00fcller M.","year":"1988","unstructured":"M\u00fcller M.; Lossick J.G.; Gorrell T.; In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex Transm Dis  1988,15(1),17-24","journal-title":"Sex Transm Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1007\/s00436-017-5627-3","volume":"116","author":"Abdel-Magied A.A.","year":"2017","unstructured":"Abdel-Magied A.A.; El-Kholya E.S.I.; Abou El-Khair S.M.; The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Parasitol Res  2017,116(11),3125-3130","journal-title":"Parasitol Res"},{"key":"ref=21","first-page":"188","volume":"35","author":"Ozcelik S.","year":"2018","unstructured":"Ozcelik S.; Ozpinar N.; Karakus S.; Akyildiz F.; Karakaya O.; Metronidazole resistance in Trichomonas vaginalis determined by molecular and conventional methods. Trop Biomed  [PMID: 336017912018,35(1),188-194","journal-title":"Trop Biomed"},{"key":"ref=22","first-page":"47","volume":"15","author":"Talari S.","year":"2011","unstructured":"Talari S.; Hosseini S.M.; Sadjadi S.M.; Detection of drug resistance gene in Trichomonas vaginalis by PCR. Feyz Med Sci J  2011,15(1),47-52","journal-title":"Feyz Med Sci J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/OLQ.0b013e318224db39","volume":"38","author":"Bosserman E.A.","year":"2011","unstructured":"Bosserman E.A.; Helms D.J.; Mosure D.J.; Secor W.E.; Workowski K.A.; Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure. Sex Transm Dis  2011,38(10),983-987","journal-title":"Sex Transm Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e02329","DOI":"10.1128\/AAC.02329-17","volume":"62","author":"Ghosh A.P.","year":"2018","unstructured":"Ghosh A.P.; Aycock C.; Schwebke J.R.; In vitro study of the susceptibility of clinical isolates of Trichomonas vaginalis to metronidazole and secnidazole. Antimicrob Agents Chemother  2018,62(4),e02329-e17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3201\/eid1806.111590","volume":"18","author":"Kirkcaldy R.D.","year":"2012","unstructured":"Kirkcaldy R.D.; Augostini P.; Asbel L.E.; Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010. Emerg Infect Dis  2012,18(6),939-943","journal-title":"Emerg Infect Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00007435-200102000-00010","volume":"28","author":"P\u00e9rez S.","year":"2001","unstructured":"P\u00e9rez S.; Fern\u00e1ndez-Verdugo A.; P\u00e9rez F.; V\u00e1zquez F.; Prevalence of 5-nitroimidazole-resistant Trichomonas vaginalis in Oviedo, Spain. Sex Transm Dis  2001,28(2),115-116","journal-title":"Sex Transm Dis"},{"key":"ref=27","first-page":"74834","author":"Bradshaw-Sydnor A.","year":"2003","unstructured":"Bradshaw-Sydnor A.; Trich or treat: Drug resistant trichomoniasis among adolescents. In: 131st Annual Meeting  2003,74834","journal-title":"In: 131st Annual Meeting"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1086\/323034","volume":"33","author":"Sobel J.D.","year":"2001","unstructured":"Sobel J.D.; Nyirjesy P.; Brown W.; Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis  2001,33(8),1341-1346","journal-title":"Clin Infect Dis"},{"key":"ref=29","first-page":"9","volume":"5","author":"Kazemi F.","year":"2010","unstructured":"Kazemi F.; Hooshyar H.; Zareikar B.; Study on ITS1 gene of Iranian Trichomonas vaginalis by molecular methods. Iran J Parasitol  [PMID: 223472602010,5(4),9-14","journal-title":"Iran J Parasitol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1128\/AAC.40.5.1121","volume":"40","author":"Narcisi E.M.","year":"1996","unstructured":"Narcisi E.M.; Secor W.E.; In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother  1996,40(5),1121-1125","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1128\/AAC.02370-13","volume":"58","author":"Paulish-Miller T.E.","year":"2014","unstructured":"Paulish-Miller T.E.; Augostini P.; Schuyler J.A.; Trichomonas vaginalis metronidazole resistance is associated with single nucleotide polymorphisms in the nitroreductase genes ntr4Tv and ntr6Tv. Antimicrob Agents Chemother  2014,58(5),2938-2943","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=32","first-page":"665","volume":"86","author":"Robinson S.C.","year":"1962","unstructured":"Robinson S.C.; Trichomonal vaginitis resistant to metranidazole. Can Med Assoc J  [PMID: 203270971962,86(14),665","journal-title":"Can Med Assoc J"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/OLQ.0b013e3181cfcd8c","volume":"37","author":"Krashin J.W.","year":"2010","unstructured":"Krashin J.W.; Koumans E.H.; Bradshaw-Sydnor A.C.; Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex Transm Dis  2010,37(7),440-444","journal-title":"Sex Transm Dis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1128\/AAC.00814-06","volume":"50","author":"Schwebke J.R.","year":"2006","unstructured":"Schwebke J.R.; Barrientes F.J.; Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother  2006,50(12),4209-4210","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=35","first-page":"24","volume":"7","author":"Rabiee S.","year":"2012","unstructured":"Rabiee S.; Bazmani A.; Matini M.; Fallah M.; Comparison of resistant and susceptible strains of Trichomons vaginalis to metronidazole using PCR method. Iran J Parasitol  [PMID: 231099582012,7(3),24-30","journal-title":"Iran J Parasitol"},{"key":"ref=36","first-page":"119","volume":"89","author":"Rukasha I.","year":"2013","unstructured":"Rukasha I.; Ehlers M.; Kock M.; Metronidazole antimicrobial drug resistance testing of Trichomonas vaginalis collected from women attending an anti-retroviral clinic, Pretoria, South Africa. Sex Transm Infect  2013,89(3),119-123","journal-title":"Sex Transm Infect"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/sti.72.2.132","volume":"72","author":"Borchardt K.A.","year":"1996","unstructured":"Borchardt K.A.; Li Z.; Zhang M.Z.; Shing H.; An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test. Sex Transm Infect  1996,72(2),132-135","journal-title":"Sex Transm Infect"},{"key":"ref=38","first-page":"46","volume":"11","author":"Matini M.","year":"2016","unstructured":"Matini M.; Maghsood A-H.; Mohebali M.; In vitro susceptibility of Iranian isolates of Trichomonas vaginalis to metronidazole. Iran J Parasitol  [PMID: 270959682016,11(1),46-51","journal-title":"Iran J Parasitol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e00912","DOI":"10.1128\/spectrum.00912-22","volume":"10","author":"Mtshali A.","year":"2022","unstructured":"Mtshali A.; Ngcapu S.; Govender K.; Sturm A.W.; Moodley P.; Joubert B.C.; In vitro effect of 5-nitroimidazole drugs against Trichomonas vaginalis clinical isolates. Microbiol Spectr  2022,10(4),e00912-e00922","journal-title":"Microbiol Spectr"},{"key":"ref=40","first-page":"120","volume":"15","author":"Pearlman R.L.","year":"2022","unstructured":"Pearlman R.L.; Van Gerwen O.T.; Kissinger P.J.; Secor W.E.; Muzny C.A.; Treatment of Trichomonas vaginalis in women in the setting of 5-nitroimidazole drug resistance. J Infect Dis  2022,15(3),120-130","journal-title":"J Infect Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1007\/s00436-020-06930-x","volume":"119","author":"Mabaso N.","year":"2020","unstructured":"Mabaso N.; Tinarwo P.; Abbai N.; Lack of association between Mycoplasma hominis and Trichomonas vaginalis symbiosis in relation to metronidazole resistance. Parasitol Res  2020,119(12),4197-4204","journal-title":"Parasitol Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.meegid.2015.07.005","volume":"34","author":"da Luz Becker D.","year":"2015","unstructured":"da Luz Becker D.; dos Santos O.; Frasson A.P.; de Vargas Rigo G.; Macedo A.J.; Tasca T.; High rates of double-stranded RNA viruses and mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil. Infect Genet Evol  2015,34,181-187","journal-title":"Infect Genet Evol"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715265376893251016064810","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/247222\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715265376893251016064810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:35:10Z","timestamp":1785753310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/247222\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715265376893251016064810","relation":{},"ISSN":["1871-5265"],"issn-type":[{"value":"1871-5265","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e18715265376893"}}